These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3960014)

  • 1. Endogenous calcitonin does not protect against hyperparathyroid bone disease in renal failure.
    Malluche HH; Faugère MC; Ritz E; Caillens G; Wildberger D
    Miner Electrolyte Metab; 1986; 12(2):113-8. PubMed ID: 3960014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Parathormone, calcitonin, 25-hydroxycalciferol and bone histology in patients with chronic renal insufficiency].
    Kokot F; Kuska J; Sledziński Z; Białas B; Luciak M
    Z Gesamte Inn Med; 1979 Nov; 34(22):665-70. PubMed ID: 549299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone histomorphometry of renal osteodystrophy in diabetic patients.
    Andress DL; Hercz G; Kopp JB; Endres DB; Norris KC; Coburn JW; Sherrard DJ
    J Bone Miner Res; 1987 Dec; 2(6):525-31. PubMed ID: 3455634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiology and treatment of renal osteodystrophy].
    Ionova D
    Vutr Boles; 1985; 24(6):23-9. PubMed ID: 3913143
    [No Abstract]   [Full Text] [Related]  

  • 6. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia.
    Quarles LD; Lobaugh B; Murphy G
    J Clin Endocrinol Metab; 1992 Jul; 75(1):145-50. PubMed ID: 1619003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the pathogenesis and pathophysiology of renal osteodystrophy. II. Bone histology of chronic renal failure patients at the time of starting hemodialysis].
    Sato T
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1145-58. PubMed ID: 7815747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic renal insufficiency and secondary hyperparathyroidism in rats. Biochemical and histological evaluation].
    Virgós MJ; Menéndez-Rodríguez P; Serrano M; González-Carcedo A; Braga S; Cannata JB
    Rev Esp Fisiol; 1993 Dec; 49(4):241-7. PubMed ID: 8209101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactive serum calcitonin and skeletal histology in chronic renal failure.
    Furlong T; Chan YL; Cornish C; McDowall D; Mahony J; Clifton-Bligh P
    Nephron; 1991; 58(2):138-43. PubMed ID: 1865968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone disease in renal failure. Clinical and histomorphometric studies.
    Nilsson P
    Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a relationship between plasma immunoreactive calcitonin and bone disease in chronic renal failure.
    Kanis JA; Heynen G; Earnshaw M; Russell RG; Woods CG; Franchimont P; Gaspar S; Oliver D; Ledingham JG
    Adv Exp Med Biol; 1977; 81():571-9. PubMed ID: 899941
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone metabolism in chronic renal failure.
    Evans RA; Flynn J; Dunstan CR; George CR; McDonnell GD
    Miner Electrolyte Metab; 1982 Apr; 7(4):207-18. PubMed ID: 7169987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of hyperparathyroid bone disease and the review of renal osteodystrophy].
    Soejima M; Takasugi M; Kuroiwa A; Okajima T; Zeze F
    Fukuoka Igaku Zasshi; 1992 Jul; 83(7):319-21. PubMed ID: 1398425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of hormonal parameters of phospho-calcium metabolism as a means of discriminating bone and joint disorders in patients with renal insufficiency].
    Poignet JL; Garnier PE; Ciancioni C; Blais D; Reinhart N; Delons S
    Pathol Biol (Paris); 1986 Oct; 34(8):948-50. PubMed ID: 3537939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathophysiology and management of renal bone disease in dialysis patients.
    Meers C; Morton AR; Toffelmire EB
    CANNT J; 1999; 9(2):24-9, 32-8; quiz 30-1, 39-40. PubMed ID: 11778255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitonin.
    Kanis JA; Earnshaw M; Heynen G; Ledingham JG; Oliver DO; Russell GG; Woods CG; Franchimont P; Gaspar S
    N Engl J Med; 1977 May; 296(19):1073-9. PubMed ID: 850517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aluminum bone content in dialysis osteodystrophy with secondary hyperparathyroidism.
    Pizzarelli F; Ballanti P; Costantini S; Mocetti P; Giordano R; Della Rocca C; Fabrizi F; Bonucci E; Maggiore Q
    Miner Electrolyte Metab; 1988; 14(2-3):129-34. PubMed ID: 3380068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy].
    Di Landro D; Zanatta GP; Simioni N; Pinzani A; Zotti D; Perin N; Bertoli M; Naso A; Ruffatti A; Gasparotto ML
    Minerva Med; 1985 Mar; 76(9-10):419-23. PubMed ID: 3982699
    [No Abstract]   [Full Text] [Related]  

  • 19. Does strict phosphorus control precipitate renal osteomalacia?
    Delmez JA; Fallon MD; Harter HR; Hruska KA; Slatopolsky E; Teitelbaum SL
    J Clin Endocrinol Metab; 1986 Apr; 62(4):747-52. PubMed ID: 3949954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.